John Hussman's ANAB Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 21,000 shares of AnaptysBio, Inc. (ANAB) worth $1.16 M, representing 0.25% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, John Hussman has initiated a new position in ANAB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
John Hussman's AnaptysBio (ANAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly AnaptysBio (ANAB) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +21,000 | New Buy | 21,000 | $55.46 |
John Hussman's AnaptysBio Investment FAQs
John Hussman first purchased AnaptysBio, Inc. (ANAB) in Q1 2026, acquiring 21,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held AnaptysBio, Inc. (ANAB) for 1 quarters since Q1 2026.
John Hussman's largest addition to AnaptysBio, Inc. (ANAB) was in Q1 2026, adding 21,000 shares worth $1.16 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 21,000 shares of AnaptysBio, Inc. (ANAB), valued at approximately $1.16 M.
As of the Q1 2026 filing, AnaptysBio, Inc. (ANAB) represents approximately 0.25% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in AnaptysBio, Inc. (ANAB) was 21,000 shares, as reported at the end of Q1 2026.